Article info
PDFEpidemiology
Original research
Assessment of risk compensation following use of the dapivirine vaginal ring in southwestern Uganda
- Correspondence to Dr Sylvia Kusemererwa, MRC/UVRI Uganda Research Unit On AIDS, Entebbe +256, Uganda; sylvia.kusemererwa{at}mrcuganda.org
Citation
Assessment of risk compensation following use of the dapivirine vaginal ring in southwestern Uganda
Publication history
- Received July 21, 2020
- Revised January 5, 2021
- Accepted January 7, 2021
- First published February 4, 2021.
Online issue publication
January 17, 2022
Article Versions
- Previous version (4 February 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.